Study Identifies Promising Drug Target in Certain Breast and Ovarian Cancers
Friday, February 13, 2015 - 11:30
in Health & Medicine
Study by Dana-Farber Cancer Institute scientists indicates that the pool of patients who can benefit from the drug olaparib is potentially much wider - and offers a ready means of identifying them.